Michael J. LaBarre - 23 Feb 2025 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role: SVP, CHIEF TECHNICAL OFFICER
Signature: /s/ James R. Oehler, Attorney-in-Fact
Issuer symbol: HALO
Transactions as of: 23 Feb 2025
Net transactions value: -$139,178
Form type: 4
Filing time: 24 Feb 2025, 17:11:03 UTC
Previous filing: 21 Feb 2025
Next filing: 27 Feb 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HALO	Common Stock	Options Exercise	$0	+4,747	+2.5%	$0.000000	197,863	23 Feb 2025	Direct
transaction	HALO	Common Stock	Tax liability	$139,178	-2,410	-1.2%	$57.75	195,453	23 Feb 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	HALO	Restricted Stock Units	Options Exercise	$0	-4,747	-25%	$0.000000	14,238	23 Feb 2025	Common Stock	4,747	$0.000000	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reported disposition of 2,410 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F2	This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.